NCT00368914View on ClinicalTrials.gov

Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

sirolimus

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

PROCEDURE

biopsy

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00368914 - Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors | Biotech Hunter | Biotech Hunter